Schedule 13D ownership disclosure

NeuroBo Pharmaceuticals, Inc.

Security class unavailable · CUSIP: 64132R206

Event date: 2022-12-22

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
65.5000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0000899140-22-000848
Form type
SC 13D/A
Filer
DONG-A ST CO., LTD
CIK
CIK 1799260
Filed
Dec 30, 2022
Reporting period
Dec 22, 2022
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub